tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karsinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - legemidler som brukes i diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 og 5.
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiske midler - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
baraclude 0.5 mg
orifarm as - entekavirmonohydrat - tablett, filmdrasjert - 0.5 mg
ocaliva 5 mg
orifarm as - obetikolsyre - tablett, filmdrasjert - 5 mg
ocaliva 10 mg
orifarm as - obetikolsyre - tablett, filmdrasjert - 10 mg
zyprexa velotab 5 mg
orifarm as - olanzapin - smeltetablett - 5 mg
zyprexa velotab 15 mg
orifarm as - olanzapin - smeltetablett - 15 mg
zyprexa velotab 10 mg
orifarm as - olanzapin - smeltetablett - 10 mg
zyprexa velotab 20 mg
orifarm as - olanzapin - smeltetablett - 20 mg